Virtus LifeSci Biotech Products ETF Rating $67.49 +0.82 (+1.23%) Closing price 04:10 PM EasternExtended Trading$67.50 +0.01 (+0.01%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.81Holdings in BBP have an aggregate rating of Moderate Buy based on 326 analyst ratings issued in the past year covering 25 companies (50.7% of the portfolio).BBP Aggregate Price Target$67.49High Prediction$67.49Average Prediction$67.49Low Prediction$67.49Holdings in BBP have an aggregate price target of $67.49 and a range of $67.49 to $67.49 covering 25 companies (50.7% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.84%CRSPCRISPR Therapeutics$59.73+1.5%3.3481 of 5 stars2.50$71.60 19.9%162.47%RYTMRhythm Pharmaceuticals$97.61+1.2%3.7823 of 5 stars3.07$101.57 4.1%15News CoverageInsider Trade2.41%IOVAIovance Biotherapeutics$2.55+4.1%4.5445 of 5 stars2.38$11.90 366.7%13Short Interest ↓2.13%MRNAModerna$28.02+5.0%4.4023 of 5 stars2.04$43.59 55.6%242.11%ARDXArdelyx$5.97+2.2%4.4183 of 5 stars3.00$11.50 92.6%10Options Volume2.09%IONSIonis Pharmaceuticals$43.78+2.2%4.483 of 5 stars2.86$59.38 35.6%142.06%LEGNLegend Biotech$37.50-0.6%3.7363 of 5 stars3.00$72.38 93.0%10Positive NewsEarnings ReportAnalyst Forecast2.06%LGNDLigand Pharmaceuticals$151.08-1.8%3.8578 of 5 stars3.00$157.00 3.9%6Short Interest ↓2.05%BBIOBridgeBio Pharma$51.32+0.3%4.3671 of 5 stars3.00$61.35 19.5%17Insider Trade2.04%AGIOAgios Pharmaceuticals$37.01+0.9%4.3923 of 5 stars2.75$56.33 52.2%8Insider Trade1.95%HRMYHarmony Biosciences$36.87+1.0%4.5091 of 5 stars3.00$51.00 38.3%101.92%KRYSKrystal Biotech$150.270.0%4.6316 of 5 stars3.00$210.75 40.2%91.92%AUPHAurinia Pharmaceuticals$12.27+1.5%2.8376 of 5 stars3.00$12.00 -2.2%3Positive News1.91%DVAXDynavax Technologies$10.79+1.6%4.4902 of 5 stars2.50$24.33 125.5%41.91%REGNRegeneron Pharmaceuticals$580.41+2.6%4.8397 of 5 stars2.81$829.65 42.9%26Positive NewsDividend AnnouncementAnalyst ForecastAnalyst RevisionGap Up1.90%ONCBeOne Medicines$321.36+3.8%0.692 of 5 stars3.00$330.89 3.0%71.90%ALNYAlnylam Pharmaceuticals$448.91+1.4%4.2629 of 5 stars2.85$403.92 -10.0%27Positive News1.89%EXELExelixis$38.31-0.4%4.9107 of 5 stars2.55$44.06 15.0%22Positive NewsAnalyst Forecast1.89%INSMInsmed$127.80+0.0%4.1201 of 5 stars2.94$129.57 1.4%16Trending NewsAnalyst ForecastAnalyst Revision1.89%BNTXBioNTech$113.52+0.7%1.6345 of 5 stars2.76$135.80 19.6%17Analyst Forecast1.89%MIRMMirum Pharmaceuticals$67.93+4.8%3.4341 of 5 stars3.13$74.13 9.1%8Insider TradeHigh Trading Volume1.89%NBIXNeurocrine Biosciences$132.90+1.2%4.8551 of 5 stars2.86$160.90 21.1%22Positive News1.88%TBPHTheravance Biopharma$13.15+1.6%2.1056 of 5 stars3.33$21.33 62.2%3News CoverageHigh Trading Volume1.87%MDGLMadrigal Pharmaceuticals$369.84-0.4%3.685 of 5 stars2.88$439.71 18.9%8News CoverageAnalyst ForecastInsider Trade1.87%HALOHalozyme Therapeutics$67.27+2.6%4.6203 of 5 stars2.18$66.56 -1.1%11Positive NewsInsider Trade This page (NYSEARCA:BBP) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access